Utilizing the triglyceride-glucose index alongside innovative anthropometric indicators to assess mortality risk in individuals with type 2 diabetes: a prospective cohort analysis - Scorecard - DentalSpire
Advertisement
Utilizing the triglyceride-glucose index alongside innovative anthropometric indicators to assess mortality risk in individuals with type 2 diabetes: a prospective cohort analysis
Clinical Scorecard: Utilizing the triglyceride-glucose index alongside innovative anthropometric indicators to assess mortality risk in individuals with type 2 diabetes: a prospective cohort analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Elderly Chinese patients with T2DM, specifically those with comorbidities.
Care Setting
Key Highlights
The triglyceride-glucose (TyG) index is a reliable surrogate marker for assessing mortality risk.
Examples of novel anthropometric indicators include body roundness index (BRI) and weight-adjusted waist index (WWI).
Composite indices combining TyG and obesity measures may enhance mortality risk prediction.
Guideline-Based Recommendations
Diagnosis
Management
Implement comprehensive risk stratification using TyG-related composite indices, including specific interventions based on results.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Target interventions based on composite biomarker assessments, such as lifestyle modifications or pharmacotherapy.
Clinical Best Practices
Integrate TyG index with innovative anthropometric measures for better risk assessment, including examples of individualized management plans.